Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiaoai Medical Technology is a leading Chinese healthcare technology company specializing in artificial intelligence-driven digital pathology solutions. Founded in 2017 and headquartered in Shanghai, the company develops sophisticated AI algorithms and high-throughput scanning hardware designed to automate and standardize the pathological diagnostic process. Their primary focus is on oncology, with commercialized products for cervical cancer screening and breast cancer diagnosis that assist pathologists in identifying malignant cells with high precision. By integrating deep learning with clinical expertise, Xiaoai Medical Technology aims to address the global shortage of pathologists and improve early cancer detection rates. The company's platform supports a wide range of applications, from routine clinical diagnostics to advanced research in companion diagnostics and drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiaoai Medical Technology.